Corporate Announcements
Financial Year 2026-2027
Financial Year 2025-2026
Closure of Credit Facility - Kotak Mahindra Bank
Execution of Loan Agreement with KEB Hana Bank
Morepen Bags supply contract under a CDMO arrangement.
Execution of Loan Agreement with Woori Bank
Unsecured Term Loan Facility From Woori Bank
Monitoring Agency Report as on December 31, 2025 - QIP Issue
Notice of Board Meeting to be held on February 10, 2026
Disclosure under Regulation 30 SEBI (LODR) - Stay on SCN
Disclosure under Regulation 30 (LODR) - SCN
Related party transaction for the half year ended September 30, 2025
Monitoring Agency Report as on September 30, 2025 - QIP Issue
Execution of Loan Agreement with Kookmin Bank
Notice of Board Meeting to be held on November 14, 2025
Transcript of 40th Annual General Meeting
Disclosure under Regulation 30 (LODR) - ESG Rating
Execution of Joint Venture Agreement and Incorporation of Joint Venture Company.
Voting results of the 40th Annual General Meeting held on September 06, 2025
Proceedings of 40th Annual General Meeting held on Saturday, 6th September, 2025
Disclosure under Reg 30 LODR- INFOMERICS Credit Rating for Long-Term Bank Facilities.
New step-down subsidiary incorporated -SIGMACHECK HEALTH PRIVATE LIMITED
Letter to members, (no e-mail id registered), comprising weblink of the Annual Report : 2024-25
Notice of 40th AGM to be held on Saturday, September 06, 2025
Monitoring Agency Report as on June 30, 2025 - QIP Issue
Notice of Board Meeting to be held on August 06, 2025
Disclosure under Regulation 30 SEBI (LODR) - Restructuring- Dr. Morepen Limited
Formation of a step down subsidiary company- Sigmacheck Health Private Limited
Disclosure under Regulation 30 SEBI (LODR) - Restructuring
Re-appointment of Mrs. (Dr.) Savita (Independent Director)
New wholly owned subsidiary incorporated in Dubai,UAE- MOREPEN LABS - FZCO
Elevation of Mr. Vivan Prashar, AVP (Projects & Engineering) as functional head, (Operations-API)
Execution of Loan Agreement with Qatar National Bank
Transcript of 'Investors Conference Call' - Q4 FY 25
Resignation of Mr. Naresh Sharma- Senior Management Personnel of the Company
Notice of Board Meeting to be held on May 12, 2025
Change in designation of Mr. Kushal Suri - Senior Management Personnel of the Company
Formation of a Wholly Owned Subsidiary in Dubai, United Arab Emirates.
Launch of four new products, namely Ticapen, UdoFix, LycoMore, and Acifix by the Company.
Change of name of subsidiary from Morepen Medtech Limited to Morepen Medipath Limited
Financial Year 2024-2025
Transcript of 39th Annual General Meeting
Acquisition of common stock by Morepen Bio, Inc., a WoS
Execution of Loan Agreement with Shinhan Bank
New Step Down Subsidiary Incorporated - Quick Med Private Limited
Intimation of formation of a step down subsidiary company
Execution of a Business Transfer Agreement with Morepen Medtech Limited
Transcript of ‘Investors Conference Call’ - Q3 FY 25
Voting results of the Extra-Ordinary General Meeting held on Monday, February 10, 2025
Proceedings of Extra-Ordinary General Meeting held on Monday, February 10, 2025
Statement of Deviation & Variation as on December 31, 2024 - QIP Issue
Monitoring Agency Report as on December 31, 2024 - QIP Issue
Notice of Board Meeting to be held on February 06, 2025
Notice of the Extra-Ordinary General Meeting to be held on Monday, February 10, 2025.
Outcome of Board Meeting- Hiving off Medical Devices Business
New Subsidiary incorporated - 'Morepen Medtech Limited'
Incorporation of a new subsidiary company.
Loan agreement with Kotak Mahindra Bank Limited
Disclosure under Regulation 30A of SEBI LODR Regulations
Change in Senior Management Personnel - Mr. Shantanu Tuli
Transcript of ‘Investors Conference Call’ - Q2 FY 25
Related party transaction for the half year ended September 30, 2024
Monitoring Agency Report as on September 30, 2024 - QIP Issue
Statement of Deviation & Variation as on September 30, 2024 - QIP Issue
Notice of Board Meeting to be held on November 11, 2024
Voting results of the 39th Annual General Meeting held on September 28, 2024
Proceedings of the 39th Annual General Meeting held on September 28, 2024
Appointment of Mr. Amrit Ravi as 'Lead - Emerging Opportunities', a Senior Management Personnel.
Business Responsibility & Sustainability Report for the financial year 2023-2024.
Notice of 39th AGM to be held on Saturday, September 28, 2024
Appointment of Mr. Sharad Jain as an Independent Director
Transcript of Earnings Conference Call - Q1 FY 25
Re-appointment of Mr. Praveen Kumar Dutt (Independent Director)
Appointment of Mr. Ranjit Khattar as an Independent Director
Change in Senior Management Personnel - Mr. Sandeep Kumar
Notice of Board Meeting to be held on August 12, 2024
Outcome of the QIP Committee Meeting held on August 5, 2024
Outcome of the QIP Committee Meeting held on August 5, 2024
Outcome of the QIP Committee Meeting held on August 1, 2024
Transcript of ‘Earnings Conference Call’ - Q4 FY24
Related party transaction for the half year ended March 31, 2024.
Change in Senior Management Personnel - Mr. Rajesh Kumar Singh
Financial Year 2023-2024
Change in Senior Management Personnel - Mr. Jatinder Pal Singh Boonga
Change in Senior Management Personnel - Mr. Nishant Jayesh Doshi
Change in Senior Management Personnel - Dr. Lalit Kumar Baregama
Transcript of Extra-Ordinary General Meeting held on March 18, 2024
Voting results of the Extra-Ordinary General Meeting held on March 18, 2024
Proceedings of the Extra-Ordinary General Meeting held on March 18, 2024
Change in Senior Management Personnel - Mrs. Amita Sharma
Notice of Extra-Ordinary General Meeting to be held on Monday, March 18, 2024.
Transcript of ‘Earnings Conference Call’ - Q3 FY24
Outcome of the Board Meeting held on January 31, 2024
Notice of Board Meeting to be held on January 31, 2024
Change in Senior Management Personnel - Ms. Rolli Saxena
Change in Senior Management Personnel - Mr. Shantanu Tuli
Transcript of ‘Earnings Conference Call’ - Q2 FY24
Related Party Transactions for the half year ended September 30, 2023
Earnings Conference Call (Q2 - FY24) scheduled to be held on Friday, November 3, 2023 at 12:15 PM
Notice of Board Meeting to be held on November 2, 2023
Transcript of 38th Annual General Meeting
Voting results of the 38th Annual General Meeting held on September 28, 2023
Proceedings of the 38th Annual General Meeting held on September 28, 2023
Change in Senior Management Personnel - Mr. Varun Suri
Online Resolution of Dispute - SEBI Circulars
Business Responsibility & Sustainability Report for the financial year 2022-2023
Notice of 38th AGM to be held on Thursday, September 28, 2023
Outcome of Board Meeting held on August 14, 2023
Outcome of the Board Meeting held on August 05, 2023
Change in Senior Management Personnel - Resignation of Mr. Dinesh Dhudabhai Moga
Notice of Board Meeting to be held on August 05, 2023
Order passed by Hon’ble Supreme Court on 29th May 2023
Notice of Board Meeting to be held on May 16, 2023
Order passed by Hon’ble NCLAT, New Delhi, on 25th April 2023
Financial Year 2022-2023
Related Party Transactions for the half year ended March 31, 2023
Successful completion of USFDA inspection of API facility at Baddi (H.P.)
Intimation of incorporation of Wholly Owned Subsidiary – MOREPEN RX LIMITED
Outcome of the Board Meeting held on February 13, 2023
Notice of Board Meeting to be held on February 13, 2023
Outcome of the Board Meeting held on February 2, 2023
Related Party Transactions for the half year ended September 30, 2022
Statement of deviation/variation in utilisation of funds for the quarter ended September 30, 2022
Outcome of the Board Meeting held on November 10, 2022
Notice of Board Meeting to be held on November 10, 2022
Transcript of 37th Annual General Meeting
Voting results of the 37th Annual General Meeting held on September 27, 2022
Proceedings of the 37th Annual General Meeting held on September 27, 2022
Outcome of the Board Meeting held on September 21, 2022
Notice of 37th AGM to be held on September 27, 2022
Outcome of the Board Meeting held on July 29, 2022
Notice of Board Meeting to be held on July 29, 2022
Resignation of Mrs. Anju Suri as Non-Executive Non-Independent Director
Outcome of the Board Meeting held on May 27, 2022
Outcome of the Board Meeting held on 9th May, 2022
Notice of Board Meeting to be held on May 05, 2022
Cessation of Mr. (Dr.) Arun Kumar Sinha as Whole-Time Director
Financial Year 2021-2022
Related Party Transactions for the half year ended March 31, 2022
Transcript of ‘Analyst/ Investor Conference Call’ - Q4 FY22
Statement of deviation/variation in utilisation of funds for the quarter ended March 31, 2022
Outcome of the Board Meeting held on March 30, 2022
Transcript of EGM dated March 05, 2022
Voting results of the Extra-Ordinary General Meeting held on March 05, 2022
Proceedings of the Extra-Ordinary General Meeting held on March 05, 2022
Corrigendum to the notice of Extra-Ordinary General Meeting
Valuation report - preferential issue of securities
Transcript of ‘Analyst/ Investor Conference Call’ - Q3 FY22
Notice of Extra-Ordinary General Meeting - 05 03 2022
Notice of Board Meeting to be held on February 08, 2022
Related Party Transaction for half year ended September 30, 2021.
Transcript of ‘Analyst/ Investor Conference Call’ - Q2 FY22.
Notice of Board Meeting to be held on November 11, 2021
Voting results of 36th Annual General Meeting held on September 28, 2021
Proceedings of the 36th Annual General Meeting held on September 28, 2021
Transcript of ‘Analyst/ Investor Conference Call’ - Q1 FY22.
Statement of deviation/variation in utilisation of funds for the quarter ended June 30, 2021
Analyst/ Investor Conference Call’ scheduled on Tuesday, 27th July, 2021 at 04:00 P.M. (IST)
Notice of Board Meeting scheduled to be held on July 27, 2021
Transcript of EGM dated May 20, 2021
Statement of deviation/variation in utilisation of funds for the quarter ended March 31, 2021
Update on preferential issue of securities approved in the EGM held on May 20, 2021
Voting results of the Extra-Ordinary General Meeting held on 20.05.2021
Proceedings of the Extra-Ordinary General Meeting held on May 20, 2021
Addendum to the Notice of Extra-Ordinary General Meeting - 20.05.2021
Transcript of Conference Call Q4-FY21
Analyst/ Investor Conference Call’ scheduled on Tuesday, 4th May 2021 at 5.30 P.M. (IST)
Notice of Board Meeting scheduled to be held on May 04, 2021
Financial Year 2020-2021
Related Party Transactions for the half year ended March 31, 2021
Transcript of Conference Call Q3-FY21
Intimation of Post Results (Q3 - FY 2020-2021) Conference Call
Notice of Board Meeting on 12.02.2021
Related Party Transactions for the half year ended September 30, 2020
Transcript of EGM Dt. 05.11.2020
Transcript of Conference Call - Q2 FY 20-21
Voting Results of EGM dt. 05.11.2020
Notice of Board Meeting on 09.11.2020
Voting Results of 35th AGM dt. 30.09.2020
Transcript of Conference Call- Q1 FY 20-21
Intimation of Post Results (Q1 - FY 2020-2021) Conference Call
Notice of Board Meeting-31.08.2020
Half yearly disclosures of related party transactions - March 2020
Transcript of Conference Call-Q4 FY20
Intimation of Post Results (Q4 & FY 2019-20) Conference Call
Financial Year 2019-2020
Disclosure for transfer of shares as per SEBI Circular dated 06 November, 2018.
Half-yearly Discloure on Related Party Transactions
Physical Transfer of Shares (Non availbility of Tranferor details)
Notice for Book Closure, AGM E-Voting
Notice of Board Meeting & Closure of Trading Window
Transcript of Conference Call.
Half-yearly Discloure on Related Party Transactions
Judgement passed by National Company Law Appellate Tribunal (‘NCLAT’), New Delhi dated 23.07.2019
Voting Results of 34th AGM dt. 13.09.2019